Education
About Us
Working with TipRanks
Follow Us
Proteome Sciences PLC (GB:PRM)
LSE:PRM
RESEARCH TOOLSreports
PRM Stock Chart & Stats
Day’s Range― - ―
52-Week Range2.22p - 5.40p
Previous CloseN/A
Volume41.42K
Average Volume (3M)58.02K
Market Cap
£8.97M
Enterprise Value23.43M
Total Cash (Recent Filing)£1.13M
Total Debt (Recent Filing)£14.52M
Price to Earnings (P/E)―
Beta0.18
Next Earnings
Aug 18, 2025EPS EstimateN/A
Next Dividend Ex-DateN/A
Dividend YieldN/A
Share Statistics
EPS (TTM)>-0.01
Shares Outstanding295,182,040
10 Day Avg. Volume52,779
30 Day Avg. Volume58,019
Financial Highlights & Ratios
PEG RatioN/A
Price to Book (P/B)0.00
Price to Sales (P/S)0.00
P/FCF Ratio0.00
Enterprise Value/Market CapN/A
Enterprise Value/RevenueN/A
Enterprise Value/Gross ProfitN/A
Enterprise Value/EbitdaN/A
Forecast
1Y Price Target
£3.00Price Target Upside-1.32% Downside
Rating ConsensusHold
Number of Analyst Covering0
Proteome Sciences News
PRM FAQ
What was Proteome Sciences PLC’s price range in the past 12 months?
Proteome Sciences PLC lowest share price was 2.22p and its highest was 5.40p in the past 12 months.
What is Proteome Sciences PLC’s market cap?
Proteome Sciences PLC’s market cap is £8.97M.
When is Proteome Sciences PLC’s upcoming earnings report date?
Proteome Sciences PLC’s upcoming earnings report date is Aug 18, 2025 which is in 10 days.
How were Proteome Sciences PLC’s earnings last quarter?
Proteome Sciences PLC released its earnings results on Apr 10, 2025. The company reported -0.004p earnings per share for the quarter, missing the consensus estimate of N/A by -0.004p.
Is Proteome Sciences PLC overvalued?
According to Wall Street analysts Proteome Sciences PLC’s price is currently Overvalued.
Does Proteome Sciences PLC pay dividends?
Proteome Sciences PLC does not currently pay dividends.
What is Proteome Sciences PLC’s EPS estimate?
Proteome Sciences PLC’s EPS estimate for its next earnings report is not yet available.
How many shares outstanding does Proteome Sciences PLC have?
Proteome Sciences PLC has 295,182,040 shares outstanding.
What happened to Proteome Sciences PLC’s price movement after its last earnings report?
Proteome Sciences PLC reported an EPS of -0.004p in its last earnings report, missing expectations of N/A. Following the earnings report the stock price went down -15.211%.
Which hedge fund is a major shareholder of Proteome Sciences PLC?
Currently, no hedge funds are holding shares in GB:PRM
Company Description
Proteome Sciences PLC
Proteome Sciences (PRM) is a leading provider in the field of proteomics, specializing in protein biomarker discovery, validation, and assay development. The company operates primarily in the healthcare and life sciences sectors, offering innovative solutions that enable advances in drug development and diagnostics. Proteome Sciences focuses on delivering high-quality proteomic services and products to pharmaceutical and biotechnology companies, as well as academic research institutions.
Technical Analysis
Genedrive
―
IXICO plc
―
Oxford BioDynamics
―
Abingdon Health PLC
―
GENinCode UK Ltd.
―